The People Pay, Corporations Cash In Problems Plague EU Medical Research Initiative

The EU spends billions in subsidies on pharmaceutical research, with funds going to the Innovative Medicines Initiative, an alliance of corporations and universities with the aim of developing new drugs. Its record has been disastrous.